Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF/FGFR signaling in tumor microenvironment
Abstract Background Fibroblast growth factors (FGFs) and their receptors (FGFRs) play a crucial role in cell fate and angiogenesis, with dysregulation of the signaling axis driving tumorigenesis. Therefore, many studies have targeted FGF/FGFR signaling for cancer therapy and several FGFR inhibitors...
שמור ב:
| Principais autores: | , , , , , , , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMC
2023-03-01
|
| סדרה: | Molecular Cancer |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1186/s12943-023-01761-7 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
